Innovatis AG and Schärfe System GmbH jointly announce
Founded in 1995, innovatis AG ranks among the leading suppliers of systems solutions for process analytics in biotechnology. With the development of the CEDEX automated cell analyzer, innovatis AG early on recognized the market requirements of the future and revolutionized the manual cell counting process previously established in the market. The Cedex, based on an image recognition measurement procedure using the Trypan blue method to determine viability, is now internationally recognized as the "Gold Standard" for cell counting in both biotechnology and R&D within the pharmaceutical industry.
Innovatis continues to make strategic market adjustments through the constant expansion of their product portfolio. With three main locations in Germany, the U.S.A. and Asia, as well as more than 20 sales partners world-wide, innovatis guarantees the necessary close proximity to customers and, thus, short response times in a cost-concious market.
Schärfe System GmbH has, since 1987, likewise developed and sold system technology recognized as a standard for quality control in cell biology. At present, these systems have strengthened their application particularly within the area of basic research. The products available under the brand name of CASY offer a complete line of equipment in themselves: from electronic cell counters/size determiners to cell analyzers that conform to GMP/21 CFR 11 standards with integrated workstations for complete cell culture control and documentation. Consumables, accessories and user software, according to individual requirements, also guarantee optimal results and security for the customer.
From December 1, 2006, the activities of both brands will be managed under the roof of innovatis AG. The Ventizz Capital Advisor Partners AG, for many years investors in innovatis AG, will support this process with a further increases in capital. Reinhard Loechner, Ventizz partner: "With this strategic merger, innovatis AG will become the strong and reliable partner for cell culture analysis".
Source: Innovatis AG